NACDS urges Biden Administration to ensure clarity or to act decisively to extend PREP Act authorities that have served Americans well, and that Americans do not want to see rolled back.
NACDS comment letter to Biden Administration urges CMS to finalize proposal, implement regulatory guardrails and standardized pharmacy measures that best serve Medicare patients and help protect pharmacy viability.
On Wednesday, March 2, the Oversight and Investigations Subcommittee of the U.S. House of Representatives Energy and Commerce Committee held a hearing titled, “Lessons from the Frontline: COVID-19’s Impact on American Health Care.”
U.S. House Energy and Commerce subcommittee to hold hearing on pandemic’s lessons.
NACDS RxIMPACT Votes begins a 36-week push to Election 2022.
INFORM Consumers Act would curb flow of stolen and counterfeit merchandise, help protect consumers and retailers from organized retail crime.
NACDS invites members to help amplify the message on NACDS’ Twitter, Facebook and LinkedIn with a “like,” share” or “retweet.”
Legislation would help reduce drug abuse and misuse by continuing to advance electronic prescribing.
NACDS is hailing an important milestone for the INFORM Consumers Act (H.R. 5502) – passage by the U.S. House of Representatives Energy and Commerce Committee.
NACDS today said that omitting pharmacy direct and indirect remuneration (DIR) fee reforms from the Build Back Better Act budget reconciliation bill will deprive Medicare beneficiaries of between $7.1 and $9.2 billion over 10 years in reduced cost-sharing for prescription drugs, according to Centers for Medicare and Medicaid Services (CMS) estimates.
